The company has nearly 800 square meters of research laboratories, including biochemical laboratory, laboratory, laboratory of molecular and immune instrument research and development laboratories, R & D team of more than 30 people, of which 30% have master degree or above. To maintain long-term good cooperation relationship between the company and the China Academy of Sciences, Zhejiang University, Beijing Institute of Technology, Dalian Medical University, Peking Union Medical College Hospital and other colleges and universities, research institutes, hospitals, realize the integration research.
The company is committed to dry chemical enzyme technology and testing platform, fluorescence immunoassay technology and quantitative detection platform, microfluidic technology platform, multilayer coating technology platform and molecular biology technology platform construction. Research and the establishment of the vaginal vaginal micro ecological analysis system, evaluation system, intestinal barrier function analysis system, the evaluation system of clinical nutrition, diarrhea classification diagnosis system, cerebrovascular disease, respiratory tract infection triage system classification diagnosis system, the COPD risk stratification system, hypertension risk stratification system, diabetes risk stratification system, dry chemical colorimetric analysis system, sepsis and multiple organ failure monitoring and warning system and a number of innovative applications. For the future, to build a full spectrum of biological information + holographic clinical information + medical big data IVD decision-making support system, for the realization of the country's accurate medical and unremitting efforts.
